These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 37532554)
1. The Involvement of Progranulin for α-Synuclein Reduction through Autolysosome Formation. Fujimori H; Ohba T; Nakamura S; Shimazawa M; Hara H Biol Pharm Bull; 2023; 46(8):1032-1040. PubMed ID: 37532554 [TBL] [Abstract][Full Text] [Related]
2. Association Between Decreased Srpk3 Expression and Increased Substantia Nigra Alpha-Synuclein Level in an MPTP-Induced Parkinson's Disease Mouse Model. Seo MH; Yeo S Mol Neurobiol; 2023 Feb; 60(2):780-788. PubMed ID: 36369636 [TBL] [Abstract][Full Text] [Related]
3. Artemisia Leaf Extract protects against neuron toxicity by TRPML1 activation and promoting autophagy/mitophagy clearance in both in vitro and in vivo models of MPP+/MPTP-induced Parkinson's disease. Wu LK; Agarwal S; Kuo CH; Kung YL; Day CH; Lin PY; Lin SZ; Hsieh DJ; Huang CY; Chiang CY Phytomedicine; 2022 Sep; 104():154250. PubMed ID: 35752074 [TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effects of osmotin in Parkinson's disease-associated pathology via the AdipoR1/MAPK/AMPK/mTOR signaling pathways. Park JS; Choe K; Lee HJ; Park TJ; Kim MO J Biomed Sci; 2023 Aug; 30(1):66. PubMed ID: 37568205 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of natural resistance-associated macrophage protein-1 (Nramp1) is associated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)/1-methyl-4-phenylpyridinium (MPP Wu KC; Liou HH; Lee CY; Lin CJ Neuropathol Appl Neurobiol; 2019 Feb; 45(2):157-173. PubMed ID: 29679389 [TBL] [Abstract][Full Text] [Related]
6. Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling. Rani L; Mondal AC J Integr Neurosci; 2024 Sep; 23(9):175. PubMed ID: 39344237 [TBL] [Abstract][Full Text] [Related]
7. Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease. Guo YL; Duan WJ; Lu DH; Ma XH; Li XX; Li Z; Bi W; Kurihara H; Liu HZ; Li YF; He RR Acta Pharmacol Sin; 2021 Apr; 42(4):518-528. PubMed ID: 32724177 [TBL] [Abstract][Full Text] [Related]
8. Decrease in Han S; Seo MH; Lim S; Yeo S Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884422 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease. Pariyar R; Bastola T; Lee DH; Seo J Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease. Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872 [TBL] [Abstract][Full Text] [Related]
11. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells. Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467 [TBL] [Abstract][Full Text] [Related]
12. Orexin B protects dopaminergic neurons from 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity associated with reduced extracellular signal-regulated kinase phosphorylation. Ma X; Cao F; Cui J; Li X; Yin Z; Wu Y; Wang Q Mol Biol Rep; 2024 May; 51(1):669. PubMed ID: 38787465 [TBL] [Abstract][Full Text] [Related]
13. Myricetin mitigates motor disturbance and decreases neuronal ferroptosis in a rat model of Parkinson's disease. Gu SC; Xie ZG; Gu MJ; Wang CD; Xu LM; Gao C; Yuan XL; Wu Y; Hu YQ; Cao Y; Ye Q Sci Rep; 2024 Jul; 14(1):15107. PubMed ID: 38956066 [TBL] [Abstract][Full Text] [Related]
14. Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models. Su Y; Liu N; Zhang Z; Li H; Ma J; Yuan Y; Shi M; Liu J; Zhao Z; Zhang Z; Holscher C Eur J Pharmacol; 2022 Jul; 926():175029. PubMed ID: 35584709 [TBL] [Abstract][Full Text] [Related]
15. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein. Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656 [TBL] [Abstract][Full Text] [Related]
16. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models. Su C; Yang X; Lou J Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the TLR/NF- Su Y; Li M; Wang Q; Xu X; Qin P; Huang H; Zhang Y; Zhou Y; Yan J Oxid Med Cell Longev; 2022; 2022():1837278. PubMed ID: 36589679 [TBL] [Abstract][Full Text] [Related]
18. Alpha-Synuclein defects autophagy by impairing SNAP29-mediated autophagosome-lysosome fusion. Tang Q; Gao P; Arzberger T; Höllerhage M; Herms J; Höglinger G; Koeglsperger T Cell Death Dis; 2021 Sep; 12(10):854. PubMed ID: 34535638 [TBL] [Abstract][Full Text] [Related]
19. Apelin-36 mitigates MPTP/MPP Zhu J; Dou S; Wang C; Jiang Y; Wang C; Cheng B Brain Res; 2019 Oct; 1721():146334. PubMed ID: 31306618 [TBL] [Abstract][Full Text] [Related]
20. Treadmill Exercise Attenuates α-Synuclein Levels by Promoting Mitochondrial Function and Autophagy Possibly via SIRT1 in the Chronic MPTP/P-Induced Mouse Model of Parkinson's Disease. Koo JH; Cho JY Neurotox Res; 2017 Oct; 32(3):473-486. PubMed ID: 28656548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]